Global Biotechnology Market Outlook 2025: Driving Growth at 13.0% CAGR | MarketsandMarkets™

Browse in-depth TOC on "Global Biotechnology Industry Outlook"
10 - Tables
20 - Figures
70 - Pages

The Global Biotech Industry Outlook for 2025 aims to provide insights into the anticipated performance of the biotech sectors, covering AI integration in drug discovery and the development of innovative therapies. The report will assess the industry's performance in 2024 relative to 2023 and highlight the significant breakthroughs and notable transformations in the biotech landscape during 2024, with expectations of continued momentum into 2025.

Some of the key developments witnessed by the biotech industry in 2024:

Key MedTech Market Players

Among the Biotech R&D and manufacturing industry, prominent players are Thermo Fisher Scientific Inc. (US), Danaher (US), Becton, Dickinson and Company (US), GE HealthCare (US), Agilent Technologies, Inc. (US), Merck KGAA (Germany), Inc (US), Qiagen (Germany), Illumina (US). F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US), Novartis (Switzerland), Merck & Co. (US), Sanofi (France), Amgen (US), Gilead Sciences (US), Biogen (US), Bristol Myers Squibb (US) and GSK (UK) are the major players in the biotech-based therapies.

In 2024, key company leaders strive to maintain their competitive leadership positions with product launches, technological advancements, regulatory approvals, and strategic deals. In 2025, key players will continue investments in research and development (R&D), multi-omics applications in biotech and biopharma settings, launch novel scientific discoveries, and focus on biotech industry-specific offerings.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=153901243

Biotech's future growth anchored for the development of advanced therapeutic medicinal products (ATMPs).

Increasing focus on development of advanced therapeutic medicinal products (ATMPs) such as gene therapies, cell therapies, antibody-drug conjugates (ADCs), and tissue-engineered products is anticipated to have significant impact on the biotechnology and healthcare industries. Growth in ATMPs will drive innovation in biomanufacturing, which will involve more sophisticated production technologies including gene editing, cell culture systems, and personalized manufacturing processes. The demand for more scalable and lower-cost production methods will spur major investments into automation and Al to enable full optimization of manufacturing efficiency. More tailored and effective therapies because of incorporation with personalized medicine will contribute more to improving patient outcomes than significantly changing the landscape of chronic disease management and rare disease treatments.

The global antibody-drug conjugates (ADCs) market is anticipated to grow at CAGR of 15.2% during 2023 – 28, reaching a market value of USD 19.80 billion in 2028. Various factors fueling this growth trajectory include increasing investments for ADC development, growing number of ADCs in clinical trials, favourable regulatory support, and rising incidence of cancer. The design and development of ADCs will benefit from ongoing improvements in antibody engineering, target selection, and cytotoxic payloads.

Some of the other key trends that the biotech industry is likely to witness in 2025:

Sustainability is one of the major driving factors in the biotechnology industry, shaping the management raw materials, packaging, and bioprocessing. Due to increasing environmental concern and regulations, biotechnology manufacturers will be pushed to adopt more sustainable practices across their operations. Sustainability has taken a front seat in EU with implementation of ECHA proposed PFAS restrictions. In 2025, the EC is expected to make sector specific decision on ban with 18-month timeline or temporary derogations, potentially including for biopharma industry. In the US as well, the US EPA has 2025-26 timeline of mandatory PFAS use reporting by manufacturers.

For more information, Inquire Now!

Related Reports:

Home Healthcare Market

Clinical Trials Market

Biomarkers Market

Artificial Intelligence in Medical Diagnostics Market

Artificial Intelligence in Genomics Market

Get access to the latest updates on Global Biotechnology Industry Outlook

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/

View original content:https://www.prnewswire.co.uk/news-releases/global-biotechnology-market-outlook-2025-driving-growth-at-13-0-cagr--marketsandmarkets-302346756.html